|

Hemithoracic Arc Radiotherapy Post Pleural Decortication

RECRUITINGN/ASponsored by Cairo University
Actively Recruiting
PhaseN/A
SponsorCairo University
Started2024-11-11
Est. completion2026-11
Eligibility
Age18 Years+
Healthy vol.Accepted

Summary

Malignant Pleural Mesothelioma is an aggressive and refractory disease , the most aggressive treatment plan offered to these patients include trimodalitiy approach with chemotherapy as the mainstay of treatment . the rationale of post operative Radiotherapy is to sterilize the post operative volume to reduce local failure meanwhile minimizing toxicities in this trial we are going to assess the safety and efficacy of Radiotherapy in Mesothelioma patients poat Pleural decortication

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Evidence of metastatic disease.
* Underwent Pleural decortication.
* Able to provide informed consent.

Exclusion Criteria:

* Poor pulmonary function tests.
* Recurrent or palliative cases.
* Inability to attend full course of Radiotherapy or follow up visits.

Conditions3

CancerLung CancerMalignant Pleural Mesothelioma

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.